JW THERAPEUTICS
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.The company focuses on development, transformation and promotion of cell-based immunotherapies that uses chimeric antigen receptor (CAR) and T cell receptor (TCR) technologies to regulate the body's immune system, enabling doctors to save the lives of cancer patients and improve the quality of life.
JW THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-02-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.jwtherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
+ 86-21-50464201
Total Funding:
190 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Global Site Tag Euro Microsoft Azure DNS US Privacy User Signal Mechanism
Similar Organizations
Amyloid Solution
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Carrick Therapeutics
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
Cryofocus Biotech
Cryofocus Biotech cryoablation device manufacturer.
Dukaan®
Dukaan is a DIY platform which enables merchants with zero programming skills to set up their e-commerce store using smartphone.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
GenFleet Therapeutics
GenFleet Therapeutics is a biotechnology developer and researcher of molecular pharmaceuticals targeting cancer treatments.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
Neukio Biotherapeutics
Neukio Biotherapeutics is a developer of allogenic immune cell therapies for treatment of cancer.
Nucros Science & Taste
Nucros is a smart-health solutions provider which links your past, present and future to offer diets.
OBiO Technology
OBiO Technology is providing overall solution of viral based gene therapy CRO services, and CDMO/CMO services.
Periotherapia
Periotherapia is a drug discovery business with triple negative breast cancer as the first indication.
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
PolyProx
PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.
PuREC
PuREC is a developer of a culture technology intended to bring efficacy to the treatment process.
S-Alpha Therapeutics
S-Alpha Therapeutics engages in the research and development of health apps and digital therapeutics.
Shanghai Cell Therapy Group
Shanghai Cell Therapy Group is a provider of cellular diagnosis center combining cellular research and treatment services.
WonDRx
Pronounced as Wonder RX. WonDRx prescription serves as the foundation of connected healthcare, it helps optimize clinical practices.
Current Employees Featured
James Li Co founder & CEO @ JW Therapeutics
Co founder & CEO
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-07-20 | Syracuse Biopharma | Syracuse Biopharma acquired by JW Therapeutics | N/A |
Investors List
ARCH Venture Partners
ARCH Venture Partners investment in Series B - JW Therapeutics
Loyal Valley Capital
Loyal Valley Capital investment in Series B - JW Therapeutics
CPE
CPE investment in Series B - JW Therapeutics
Temasek Holdings
Temasek Holdings investment in Series B - JW Therapeutics
Juno Therapeutics
Juno Therapeutics investment in Series B - JW Therapeutics
Mirae Asset Global Investments
Mirae Asset Global Investments investment in Series B - JW Therapeutics
CR-CP Life Science Fund
CR-CP Life Science Fund investment in Series B - JW Therapeutics
Sequoia Capital China
Sequoia Capital China investment in Series B - JW Therapeutics
Oriza Holdings
Oriza Holdings investment in Series B - JW Therapeutics
WuXi AppTec
WuXi AppTec investment in Series B - JW Therapeutics
Official Site Inspections
http://www.jwtherapeutics.com Semrush global rank: 6.77 M Semrush visits lastest month: 804
- Host name: 42.159.132.179
- IP address: 42.159.132.179
- Location: Shanghai China
- Latitude: 31.0449
- Longitude: 121.4012
- Timezone: Asia/Shanghai
More informations about "JW Therapeutics"
上海药明巨诺生物科技有限公司
药明巨诺（港交所代码：2126）是一家独立的、创新型的生物科技公司，专注于研发、生产及商业化细胞免疫治疗产品，并致力于以创新为先导，成为细胞免疫治疗引领者。创建于2016年，药明巨诺已成功打造了国际领先的细胞免疫治疗的 …See details»
Overview - JW Therapeutics
JW Therapeutics (HKEX: 2126) is an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, and …See details»
JW Therapeutics - Crunchbase Company Profile
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.The company focuses on development, …See details»
Jw Company Profile | Management and Employees List - Datanyze
Smith@jwtherapeutics.com: Your Questions, Our Answers Get Free Access to Jw Contacts Info. What is Jw revenue? Jw revenue is $23.3 M. How many employees does Jw have? Jw has …See details»
Corporate Governance | JW Therapeutics
Procedures for Shareholders to Propose a Person for Election as a Director of the CompanySee details»
Jw - Overview, News & Similar companies | ZoomInfo.com
View Jw (www.jwtherapeutics.com) location in Chongqing, China , revenue, industry and description. Find related and similar companies as well as employees by title and much more. …See details»
JW Therapeutics 药明巨诺 - LinkedIn
JW Therapeutics is an innovative biotech company focusing on the latest clinical cell therapy technology. It is commited to the development, transformation and promotion of breakthrough …See details»
JW Therapeutics Company Profile - Office Locations, Competitors …
JW Therapeutics has 5 employees across 4 locations and $90 m in total funding,. See insights on JW Therapeutics including office locations, competitors, revenue, financials, executives, …See details»
JWCTF Company Description - Stock Analysis
Jan 24, 2025 JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs …See details»
JW Therapeutics - PitchBook
JW Therapeutics General Information Description. JW (Cayman) Therapeutics Co Ltd is a clinical-stage cell therapy company in China. It focuses on developing, manufacturing, and commercializing breakthrough cell-based …See details»
JW Therapeutics - Funding, Financials, Valuation & Investors
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.See details»
JW Therapeutics Announces its Cell Immunotherapy Drugs Have ...
Nov 9, 2022 For more information, please visit www.jwtherapeutics.com. Forward-Looking Statements. The forward-looking statements are based on the management's expectations …See details»
JW Therapeutics (Suzhou) Co., Ltd. - Drug pipelines, Patents
Www.jwtherapeutics.com. Private Company | 2018 | Jiangsu Sheng, China | www.jwtherapeutics.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
JW Therapeutics - VentureRadar
Similar Companies: CARsgen China Publicly Traded CARsgen is a leading immunotherapy company focused on the development of new chimeric antigen receptor T (CAR-T) cell …See details»
History - JW Therapeutics
Became the market authorization holder (MAH) for cell therapy product, and entered commercial stageSee details»
JW Therapeutics (China) Funding: $190M - medicalstartups.org
Jan 22, 2025 JW is focused on revolutionizing medicine by re-engaging the body's immune system to treat...See details»
2seventy bio and JW Therapeutics Announce Intent To Expand …
Sep 12, 2023 For more information, please visit www.jwtherapeutics.com. About 2seventy bio. Our name, 2seventy bio, reflects why we do what we do - TIME. Cancer rips time away, and …See details»
JW Therapeutics Announces Two Appointments to Strengthen …
SHANGHAI, Jan. 9, 2022 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent, innovative biotechnology company focusing on developing, manufacturing and …See details»
JW Therapeutics Announces its Cell Immunotherapy Drugs Have ...
SHANGHAI, CHINA, November 9, 2022 - JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and …See details»
X4 Pharmaceuticals Announces Strategic Restructuring to Drive …
6 days ago These forward-looking statements are neither promises nor guarantees of future performance, and are subject to a variety of risks and uncertainties, many of which are beyond …See details»